Ser83
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser83  -  GMF-beta (human)

Site Information
QHDDGRVsyPLCFIF   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 451485

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
astrocyte ( 1 ) , brain ( 1 )

Upstream Regulation
Kinases, in vitro:
PKACA (human) ( 1 , 2 )
Treatments:
LPS ( 1 )

Downstream Regulation
Effects of modification on biological processes:
signaling pathway regulation ( 1 )

References 

1

Vattathara JJ, et al. (2020) Substrate Specific Inhibitor Designed against the Immunomodulator GMF-beta Reversed the Experimental Autoimmune Encephalomyelitis. Sci Rep 10, 3790
32123210   Curated Info

2

Zaheer A, Lim R (1997) Protein kinase A (PKA)- and protein kinase C-phosphorylated glia maturation factor promotes the catalytic activity of PKA. J Biol Chem 272, 5183-6
9030586   Curated Info